BRK-B vs HOMB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Home BancShares (HOMB) presents a conflicting profile: it is fundamentally undervalued based on the Graham Number ($34.59) and Intrinsic Value ($29.77), yet it exhibits severe operational deterioration as evidenced by a weak Piotroski F-Score of 2/9. While the dividend is sustainable with a low payout ratio (33.74%), the combination of stagnant growth, bearish insider selling, and a 0/100 technical trend suggests a value trap scenario. The stock is trading at a discount, but the lack of internal health momentum offsets the valuation appeal.
Compare Another Pair
Related Comparisons
BRK-B vs HOMB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Home BancShares, Inc. (HOMB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.